Summit Therapeutics Inc. Common Stock SMMT
$17.40
+1.58%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (6 Buy · 7 Hold · 0 Sell)
- Average Price Target
- $26.99
- Implied Upside
- +55.1%
- Price Target Range
- $11.90 – $40.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-26 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | — |
| 2026-08-25 | BernsteinJeffrey Walch |
Upgrades | Underperform → Market perform | $10 → $12 |
| 2026-08-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | — |
| 2026-08-12 | Leerink PartnersDaina Graybosch |
Upgrades | Underperform → Market perform | $12 → $13 |
| 2026-07-24 | StifelDara Azar |
Maintains | Buy | $45 → $38 |
| 2026-07-24 | GuggenheimBrad Canino |
Maintains | Buy | $40 → $38 |
| 2026-07-23 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Neutral | — |
| 2026-05-22 | BernsteinJeffrey Walch |
Initiates coverage on | Underperform | $8 |
| 2026-05-22 | HC Wainwright & Co.Mitchell S. Kapoor |
Downgrades | Buy → Neutral | — |
| 2026-05-04 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $30 → $23 |
| 2026-05-01 | Piper SandlerKelsey Goodwin |
Maintains | Neutral | $17 → $16 |
| 2026-04-08 | StifelDara Azar |
Initiates coverage on | Buy | $45 |
| 2026-03-16 | JefferiesClara Dong |
Downgrades | Buy → Hold | $42 → $15 |
| 2026-02-24 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $40 → $30 |
| 2026-02-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $40 |
| 2026-01-30 | CitizensReni J. Benjamin |
Reiterates | Market outperform | $40 |
| 2025-12-17 | BarclaysEtzer Darout |
Upgrades | Underweight → Equal-weight | $16 → $18 |
| 2025-11-18 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2025-10-22 | GuggenheimBrad Canino |
Reiterates | Buy | $40 |
| 2025-10-21 | BarclaysEtzer Darout |
Maintains | Underweight | $13 → $16 |
| 2025-10-21 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $50 → $40 |
| 2025-10-20 | CitigroupYigal Nochomovitz |
Maintains | Buy | $35 → $40 |
| 2025-10-20 | JMP SecuritiesReni J. Benjamin |
Reiterates | Market outperform | $40 |
| 2025-09-17 | BarclaysEtzer Darout |
Initiates coverage on | Underweight | $13 |
| 2025-09-16 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
| 2025-09-08 | Cantor FitzgeraldEric Schmidt |
Reiterates | Overweight | — |
| 2025-09-08 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
| 2025-09-04 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $40 |
| 2025-09-03 | JMP SecuritiesReni J. Benjamin |
Reiterates | Market outperform | $40 |
| 2025-09-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $50 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $17.40
- Market Cap
- $13.67 billion
- 52-Week Range
- $12.07 – $30.98
- Average Volume
- 5.35 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.